HomeKRONOX › Filing
🔔 Get instant alerts when KRONOX files quarterly results on BSE Start free trial →

Anuual Report for the year 2025-26

Filed: 24 Aug 2026, 16:41 IST Exchange: BSE Category: Financial Results — Press Release
Press Release - FY26 - Revenue 101.22 Cr +1% y-y; PAT 27.66 Cr +8.6% y-y - Total income rose 3.6% to Rs. 106.41 Cr; net profit increased 8.61% to Rs. 27.66 Cr - Dividend recommended at Rs. 0.50/share (5%) for FY26 - Capex underway for Unit IV at Dahej; production expected within 2 years - Strong operating margins: EBITDA margin 33.86%, PAT margin 25.99% - Export revenue 32.39% of total revenue - Board meeting scheduled for AGM on 2026-09-16 - No change in business nature or board composition - CSR spend Rs. 57.53 Lakhs on education, animal welfare, heritage - Robust internal controls and compliance with corporate governance - Debt-equity ratio low at 0.01; net worth Rs. 116.13 Cr - MD & CFO certified accuracy and compliance of financials
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 KRONOX — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add KRONOX to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Kronox Lab Sciences Limited

Important. The summary above is generated automatically from Kronox Lab Sciences Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.